Epicore Biosystems, Inc., Completes Initial Closing of $35 million Series B Financing
McCarthy Duffy LLP advised Epicore Biosystems, Inc. (“Epicore Biosystems”) in connection with the initial closing of its $35 million Series B equity financing.
The Series B round, which initially closed on December 11, 2024, was led by The Steele Foundation for Hope, a 501(c)(3) charitable organization, with participation from existing investors. This significant funding will support Epicore Biosystem’s growth strategy, particularly its development and deployment of its advanced, real time, noninvasive biosensor technology for monitoring hydration, health biomarkers, and environmental toxins.
Attorneys Tom Cox, Elaine Vorberg and Chris Diaguila led the McCarthy Duffy team supporting Epicore Biosystems.
About Epicore Biosystems:
Epicore Biosystems is a digital health company focused on creating advanced sweat-sensing wearables and cloud analytics to provide real-time, personalized hydration and health insights to individuals. Founded in 2017, with the support of McCarthy Duffy LLP, Epicore Biosystems was recently named in Fast Company’s Fourth Annual List of Next Big Things in Tech.